NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice

Human Immunology

Volumn 60, Issue 7, 1999, Pages 583-590

  Abraham, Roshini S ^a   Wilson, S Brian ^c   De Souza Jr , Nelson F ^b   Strominger, Jack L ^c   Munn, Stephen R ^d   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antigen processing; GAD 65; MHC class II; Non MHC genes

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC RISK; HLA SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 0032814041     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00057-9     Document Type: Article

References (47)

1. Vyse T.J., Todd J.A. Genetic analysis of autoimmune disease. Cell. 85:1996;311.
2. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D. Analysis of HLA DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 322:1990;1836.
3. Lernmark A. Molecular biology of IDDM. Diabetologia. 37:(Supp. 2):1994;S73.
4. Sanjeevi C.B., DeWeese C., Landin-Olsson M., Kockum I., Dahlquist G., Lernmark A., Lybrand T.P. Analysis of critical residues of HLA DQ6 molecules in IDDM. Tissue Antigens. 50:1997;61.
5. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C., Jenkins S.C., Palmer S.M., Balfour K.M., Rowe B.R., Farall M., Barnett A.H., Bain S.C., Todd J.A. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 371:1994;130.
6. Hashimoto L., Habita C., Beressi J.P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J.I., Djoulah S., James M.R., Froguel P., Weissenbach J., Lathrop G.M., Julier C. Genetic mapping of a susceptibility locus for IDDM on chromosome 11q. Nature. 371:1994;161.
7. Serreze D.V., Leiter E.H. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol. 6:1994;900.
8. Prochazka M., Serreze D.V., Worthen S.M., Leiter E.H. Genetic control of diabetogenesis in NOD/Lt mice development and analysis of congenic stocks . Diabetes. 38:1989;1446.
9. Chesnut K., She J.X., Cheng I., Muralidharan K., Wakeland E.K. Characterization of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain. Mammal Genome. 4:1993;549.
10. Harrison L.C. Islet cell antigens in insulin-dependent diabetes. Immunol Today. 13:1992;348.
11. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 298:1982;167.
12. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., Adler D.A., Barmeier H., Mathewes S., Grant F.J., Foster D., Lernmark A. Cloning and promary structure of a human islet isoform of GAD from chromosome 10. Proc Natl Acad Sci USA. 88:1991;8337.
13. Harrison L.C., Honeyman M.C., DeAizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. Inverse relation between humoral and cellular immunity to GAD in subjects at risk if IDDM. Lancet. 341:1993;1365.
14. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature. 366:1993;72.
15. Chao C.C., McDevitt H.O. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics. 46:1997;29.
16. Quinn A., Sercarz E.E. T cells with multiple fine specificities are used by NOD mice in the response to GAD [524-543]. J Autoimmunity. 9:1996;365.
17. Wei B-Y, Martin J, Savarirayan S, Little R, David CS: Transgenic mice with MHC class II genes: the use in the study of allelic α/β chain pairing and the production of engineered mice with mutant I-A genes (p 237). In Egorov IK, David CS (eds): Transgenic Mice and Mutants in MHC Research. Heidelberg, Springer-Verlag, 1990.
18. Nabozny G.H., Baisch J.M., Cheng S., Cosgrove D., Griffiths M., Luthra H.S., David C.S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis a novel model for human polyarthritis . J Exp Med. 183:1996;27.
19. Okada K., Boss J.M., Prentice H., Spies T., Mengler R., Auffray C., Lillie J., Grossberger D., Strominger J.L. Gene organization of DC and DX subregions of the human MHC. Proc Natl Acad Sci USA. 82:1985;3410.
20. Lohmann T., David R., Leslie G., Mohammed H., Geysen M., Rodda S., Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 343:1994;1607.
21. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., Tobin A.J. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA. 89:1992;2115.
22. Chen S., Evans G.A. A simple screening method for transgenic mice using the polymerase chain reaction. Biotechniques. 8:1990;32.
23. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051.
24. Todd J.A., Bell J.I., McDevitt H.O. HLA DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599.
25. Kim S.J., Holbeck S.L., Nisperos B., Hansen J.A., Maeda H., Nepom G.T. Identification of a polymorphic variant associated with HLA DQw3 and characterized by specific restriction sites within the DQ beta-chain gene. Proc Natl Acad Sci USA. 82:1985;8139.
26. Tosi G., Brunelli S., Mantero G., Maglini A.R., Soffiati M., Pinelli L., Tridente G., Accolla R.S. The complex interpaly of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for insulin-dependent diabetes mellitus. Mol Immunol. 31:1994;429.
27. Acha-Orbea H., McDevitt H.O. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci USA. 84:1987;2435.
28. Wu J., Longmate J.A., Adamus G., Hargrave P.A., Wakeland E.K. Interval mapping of quantitative trait loci controlling humoral immunity to exogenous antigens evidence that non-MHC immune response genes may also influence susceptibility to autoimmunity . J Immunol. 157:1996;2498.
29. Christadoss P. Immunogenetics of experimental autoimmune myasthenia gravis. Crit Reviews in Immunol. 9:1989;247.
30. Kwan-Lim G.E., Maizels R.M. MHC and non-MHC-restricted recognition of filarial surface antigens in mice transplanted with adult Brugia malayi parasites. J Immunol. 145:1990;1912.
31. Jepson A., Banya W., Sissay-Joof F., Hassan-King M., Nunes C., Bennett S., Whittle H. Quantification of the relative contribution of major histocompatibility complex [MHC] and non-MHC genes to human immune responses to foreign antigens. Infect & Immunity. 65:1997;872.
32. Thomsen A.R., Marker O. MHC and non-MHC genes regulate elimination of lymphocytic choriomeningitis virus and antiviral cytotoxic T lymphocyte and delayed-type hypersensitivity mediating T lymphocyte activity in parallel. J Immunol. 142:1989;1333.
33. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69.
34. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K.D. Dominance and crypticity of T cell antigenic determinants. Ann Rev Immunol. 11:1993;729.
35. Moreno J., Vignali D.A.A., Nadimi F., Fuchs S., Adorini L., Hammerling G.J. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J Immunol. 147:1991;3306.
36. Vidard L., Rock K.L., Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells effect of cell culture on antigen processing ability . J Immunol. 149:1992;1905.
37. Lipham W.J., Redmond T.M., Takahashi H., Berzofsky J.A., Wiggert B., Chader G.J., Gery I. Recognition of peptides that are immunopathogenic but cryptic mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes . J Immunol. 146:1991;3757.
38. King C., Davies J., Mueller R., Lee M.S., Krahl T., Yeung B., O'Connor E., Sarvetnick N. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity. 8:1998;601.
39. Falcone M., Lee J., Patstone G., Yeung B., Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD 65 antigen in nonobese diabetic mice. J Immunol. 161:1998;1163.
40. Boehncke W.H., Takeshita T., Pendleton C.D., Houghten S., Sadegh-Nasseri S., Racioppi L., Berzofsky J.A., Germain R.N. The importance of dominant negative effects of amino acid side chain substitution in peptide-mHC molecule interactions and T cell recognition. J Immunol. 150:1993;331.
41. Grewal I.S., Moudgil K.D., Sercarz E.E. Hindrance of binding to class II MHC molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. Proc Natl Acad Sci USA. 92:1995;1779.
42. Bhayani H., Carbone F.R., Paterson Y. The activation of pigeon cytocrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant. J Immunol. 141:1989;377.
43. Brett S.J., Cease K.B., Berzofsky J.A. Influences of antigen processing on the expression of the T cell repertoire evidence for MHC-specific hindering structures on the products of processing . J Exp Med. 168:1988;357.
44. Kropshofer H., Vogt A.B., Moldenhauer G., Hammer J., Blum J.S., Hammerling G.J. Editing of the HLA-DR peptide repertoire by HLA-DM. EMBO J. 15:1996;6144.
45. Katz J.F., Stebbins C., Appella E., Sant A.J. Invariant chain and DM edit self-peptide presentation by MHC class II molecules. J Exp Med. 184:1996;1747.
46. Perkins D.L., Wang Y., Fruman D., Seidman J.G., Rimm I.J. Immunodominance is altered in TCR-β chain transgenic mice without the generation of a hole in the repertoire. J Immunol. 146:1991;2960.
47. Nikcevich K.M., Kopielski D., Finnegan A. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. J Immunol. 153:1994;1015.